Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Chronic Myelogenous Leukemia (CML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01606579
What this trial is testing

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid Leukemia
Prism Pharma Co., Ltd. 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385
What this trial is testing

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Center for International Blood and Marrow Transplant Research 313
Testing effectiveness (Phase 2)Study completedNCT00691015
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Barbara Ann Karmanos Cancer Institute 48
Large-scale testing (Phase 3)Ended earlyNCT05413915
What this trial is testing

Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML

Who this might be right for
Chronic Myeloid LeukemiaChronic Myeloid Leukemia, BCR/ABL-PositiveChronic Myeloid Leukemia in Remission
Sarit Assouline 8
Testing effectiveness (Phase 2)UnknownNCT04043676
What this trial is testing

Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Fundación Teófilo Hernando, Spain 40
Testing effectiveness (Phase 2)Study completedNCT01885897
What this trial is testing

IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT

Who this might be right for
Acute Myelogenous Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Myelodysplastic Syndromes (MDS)+4 more
Masonic Cancer Center, University of Minnesota 33
Not applicableUnknownNCT03709017
What this trial is testing

Iclusig PMS in CML or Ph+ALL Patients

Who this might be right for
Chronic Myeloid LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia
Korea Otsuka Pharmaceutical Co., Ltd. 50
Not applicableStudy completedNCT02057185
What this trial is testing

Occupational Status and Hematological Disease

Who this might be right for
Chronic Myeloid LeukemiaChronic Lymphocytic LeukemiaMyelodysplastic Syndrome+2 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 141
Not applicableStudy completedNCT01683123
What this trial is testing

Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeMyeloproliferative Disorders+1 more
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 143
Early research (Phase 1)Study completedNCT00677859
What this trial is testing

Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia

Who this might be right for
Hematologic Malignancies
Healios K.K. 36
Not applicableStudy completedNCT04666025
What this trial is testing

SARS-CoV-2 Donor-Recipient Immunity Transfer

Who this might be right for
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+10 more
City of Hope Medical Center 26
Testing effectiveness (Phase 2)Ended earlyNCT01118013
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder+3 more
Alliance for Clinical Trials in Oncology 6
Testing effectiveness (Phase 2)Study completedNCT01517035
What this trial is testing

Improving Blood Stem Cell Collection and Transplant Procedures

Who this might be right for
Myelodysplastic Syndrome (MDS)Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 43
Early research (Phase 1)Study completedNCT00303290
What this trial is testing

PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML

Who this might be right for
Chronic Myeloid Leukemia
M.D. Anderson Cancer Center 76
Large-scale testing (Phase 3)Active Not RecruitingNCT03722420
What this trial is testing

Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)

Who this might be right for
Chronic Myeloid Leukemia, Chronic Phase
Il-Yang Pharm. Co., Ltd. 238
Testing effectiveness (Phase 2)Study completedNCT00022048
What this trial is testing

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Stanford University
Not applicableEnded earlyNCT02455024
What this trial is testing

An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®

Who this might be right for
Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
Ariad Pharmaceuticals 3
Testing effectiveness (Phase 2)UnknownNCT01227135
What this trial is testing

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

Who this might be right for
Leukemia
Lynn McMahon 66
Early research (Phase 1)Study completedNCT00953758
What this trial is testing

PF-04449913 In Select Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Pfizer 47
Early research (Phase 1)Study completedNCT00077558
What this trial is testing

3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Next Page